Log in to save to my catalogue

Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors...

Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2179392448

Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads

About this item

Full title

Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads

Publisher

Cham: Springer International Publishing

Journal title

Journal of computer-aided molecular design, 2019-03, Vol.33 (3), p.357-366

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Tuberculosis (TB) remains a major threat to human health. This due to the fact that current drug treatments are less than optimal and the increasing occurrence of multi drug-resistant strains of etiological agent,
Mycobacterium tuberculosis
(
Mt
). Given the wide-spread significance of this disease, we have undertaken a design and evalu...

Alternative Titles

Full title

Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2179392448

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2179392448

Other Identifiers

ISSN

0920-654X

E-ISSN

1573-4951

DOI

10.1007/s10822-019-00184-1

How to access this item